Quay Pharma has announced their investment in specialist isolation facilities at its headquarters in Deeside to support the development of potent drugs in a protective environment.   The isolation suites are temporary structures, assembled to GMP requirements, that provide a highly flexible solution for analytical testing, and the development and small-scale processing of new drugs.  Each suite is built to Quay’s design specifications in order to handle the particular characteristics of ...